BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, is pleased to announce that Daniela Sica has joined the firm as Vice President, Business Development, Pharma and Biotech. Daniela has extensive experience in the pharmaceutical and biotech space, and is based out of Alira Health’s Barcelona, Spain office.
Welcome Daniela Sica, Vice President, Business Development, Pharma and Biotech
“We are thrilled to welcome Daniela to the Alira Health Team,” said Benjamin Chambon, Chief Commercial Officer and EVP, Transaction Advisory. “Her notable experience in the pharma and biotech field will play a critical role in further enhancing the Alira Health lifecycle offering, and, in turn, continuing to improve synergies across our practice areas for the benefit of our clients.”
“I have been following the evolution of Alira Health for several years, prior to joining the team,” said Daniela. “I have always admired the passion and commitment of the founders and leadership team, and the depth of expertise within the company. I am thrilled to join Alira Health at this exciting stage of its development.”
Daniela has over 25 years of management experience with pharmaceutical and biotech companies, and CDMOs. She has worked in business development, alliance management, and strategic planning with worldwide responsibilities, building a strong network of international relationships. Daniela has strong transaction experience, having led negotiations in co-development deals involving some of the largest global pharma companies.
Daniela sits on several biotech evaluation commissions, supporting biotech accelerators in their investment decisions. She has a degree in Food Science and Technology from the University of Milan, with a qualification as a Food Science Expert.